Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17470568rdf:typepubmed:Citationlld:pubmed
pubmed-article:17470568lifeskim:mentionsumls-concept:C0151744lld:lifeskim
pubmed-article:17470568lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:17470568lifeskim:mentionsumls-concept:C0013725lld:lifeskim
pubmed-article:17470568lifeskim:mentionsumls-concept:C0035126lld:lifeskim
pubmed-article:17470568lifeskim:mentionsumls-concept:C1421467lld:lifeskim
pubmed-article:17470568lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:17470568pubmed:issue11lld:pubmed
pubmed-article:17470568pubmed:dateCreated2007-9-3lld:pubmed
pubmed-article:17470568pubmed:abstractTextRecent evidence implicates the neuronal transient receptor potential vanilloid receptor 1 (TRPV1), expressed on sensory C-fibers, as playing an important endogenous protective role in limiting the damaging effects of myocardial I/R injury. In neurons the 12-lipoxygenase (12-LOX) arachidonic acid (AA) metabolite, 12(S)-HpETE, has been proposed as the endogenous ligand for TRPV1. However, whether 12(S)-HpETE underlies TRPV1 channel activation during I/R is unknown. Treatment of isolated Langendorff rat hearts with a 12-LOX/AA cocktail significantly attenuated I/R injury (approximately 40% inhibition of infarct size), an effect reversed by the 12-LOX inhibitor baicalein or after chemical desensitization of local sensory C-fiber afferents using capsaicin. Both 12(S)-HpETE and AA caused dose-dependent coronary vasodilatation (approximately EC50s of 6x10(-19) and 1x10(-7), respectively) that was profoundly suppressed by the TRPV1 antagonist capsazepine, in hearts of TRPV1 knockout mice compared with wild-type mice, or by treatment with a CGRP antagonist. In addition, I/R itself stimulates up-regulation of TRPV1 expression in both the cell bodies located within the dorsal root ganglia and locally within the myocardium. Together, our data identify a novel 12-LOX/AA/TRPV1 pathway activated and up-regulated during I/R injury, providing an endogenous damage-limiting mechanism whose targeting may prove useful in treating myocardial infarction.lld:pubmed
pubmed-article:17470568pubmed:languageenglld:pubmed
pubmed-article:17470568pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:citationSubsetIMlld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17470568pubmed:statusMEDLINElld:pubmed
pubmed-article:17470568pubmed:monthSeplld:pubmed
pubmed-article:17470568pubmed:issn1530-6860lld:pubmed
pubmed-article:17470568pubmed:authorpubmed-author:CaylaCecileClld:pubmed
pubmed-article:17470568pubmed:authorpubmed-author:AhluwaliaAmri...lld:pubmed
pubmed-article:17470568pubmed:authorpubmed-author:McDonaldMiche...lld:pubmed
pubmed-article:17470568pubmed:authorpubmed-author:SextonAlisonAlld:pubmed
pubmed-article:17470568pubmed:authorpubmed-author:ThiemermannCh...lld:pubmed
pubmed-article:17470568pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17470568pubmed:volume21lld:pubmed
pubmed-article:17470568pubmed:ownerNLMlld:pubmed
pubmed-article:17470568pubmed:authorsCompleteYlld:pubmed
pubmed-article:17470568pubmed:pagination2695-703lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:meshHeadingpubmed-meshheading:17470568...lld:pubmed
pubmed-article:17470568pubmed:year2007lld:pubmed
pubmed-article:17470568pubmed:articleTitle12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1.lld:pubmed
pubmed-article:17470568pubmed:affiliationWilliam Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, Charterhouse Square, London, UK.lld:pubmed
pubmed-article:17470568pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17470568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17470568lld:pubmed